29 April 2026, Mumbai: Rallis India Limited announced its financial results for the quarter and year ended March 31, 2026, reporting its highest-ever EBITDA of ₹362 crore and an improved EBITDA margin of 12.5%.
For FY26, the company reported revenue growth of 9% to ₹2,897 crore, while Profit After Tax stood at ₹184 crore.
Business Performance: Q4 and FY26
The company delivered broad-based growth across key business segments during the year. The B2B Exports business, including Custom Synthesis Manufacturing (CSM), grew by 17%, while the Seeds business registered growth of 15%.
The Crop Care business grew by 8%, supported by a 5% rise in Domestic Formulations. The Soil and Plant Health (SPH) segment also posted 8% growth.
During Q4 FY26, revenue grew by 6% year-on-year, driven by 5% volume growth and 1% price growth. In the quarter, the Crop Care business grew by 5%, while the B2C segment delivered strong growth of 15%. The B2B business declined by 7%, whereas the Seeds business recorded robust growth of 23%.
Key Highlights: Q4 FY26
During the quarter, the company launched two new insecticide products and achieved highest-ever production levels for select products. In the Seeds segment, two new products were also introduced.
Management Comment
Commenting on the results, Dr. Gyanendra Shukla, Managing Director and CEO of Rallis India Limited, said the company’s performance reflects strong execution, product innovation, and continued focus on growth across businesses.
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
